Northern Financial Advisors Inc Trims Stock Position in Colgate-Palmolive Company (NYSE:CL)

Northern Financial Advisors Inc cut its position in shares of Colgate-Palmolive Company (NYSE:CL) by 5.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,510 shares of the company’s stock after selling 330 shares during the period. Northern Financial Advisors Inc’s holdings in Colgate-Palmolive were worth $516,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the company. Westend Capital Management LLC increased its position in shares of Colgate-Palmolive by 111.1% during the first quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock valued at $25,000 after acquiring an additional 140 shares during the last quarter. Cornerstone Planning Group LLC grew its holdings in shares of Colgate-Palmolive by 1,913.3% in the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock valued at $28,000 after purchasing an additional 287 shares in the last quarter. Vermillion Wealth Management Inc. acquired a new position in shares of Colgate-Palmolive in the fourth quarter valued at approximately $31,000. Accredited Wealth Management LLC acquired a new position in shares of Colgate-Palmolive in the fourth quarter valued at approximately $34,000. Finally, Bernard Wealth Management Corp. acquired a new position in shares of Colgate-Palmolive in the fourth quarter valued at approximately $33,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $88.82 on Thursday. The stock has a market cap of $71.98 billion, a PE ratio of 25.09, a price-to-earnings-growth ratio of 4.68 and a beta of 0.37. Colgate-Palmolive Company has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The firm’s fifty day simple moving average is $90.33 and its 200-day simple moving average is $90.33. The company has a quick ratio of 0.54, a current ratio of 0.85 and a debt-to-equity ratio of 8.96.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.86 by $0.05. The company had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.92 billion. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The firm’s quarterly revenue was down 3.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.86 EPS. Analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 18th will be issued a $0.52 dividend. The ex-dividend date is Friday, July 18th. This represents a $2.08 annualized dividend and a yield of 2.34%. Colgate-Palmolive’s payout ratio is 58.76%.

Analyst Ratings Changes

A number of brokerages recently issued reports on CL. Wall Street Zen downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Wednesday, May 7th. UBS Group reduced their price objective on shares of Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating for the company in a research report on Thursday, July 17th. Barclays boosted their price objective on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 15th. Wells Fargo & Company boosted their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “underweight” rating in a research report on Wednesday, April 2nd. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the stock an “overweight” rating in a research report on Monday, April 28th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $100.64.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.